{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:58:02Z","timestamp":1764172682700,"version":"3.40.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98135-4","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T09:45:06Z","timestamp":1744969506000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improved acid-driven inhibition of effector T cell function by a pHLIP variant-conjugated PD-L1"],"prefix":"10.1038","volume":"15","author":[{"given":"Hang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mianjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longlong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiannan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanqiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"key":"98135_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","volume":"23","author":"RJ Greenwald","year":"2005","unstructured":"Greenwald, R. J., Freeman, G. J. & Sharpe, A. H. The B7 family revisited. Annu. Rev. Immunol. 23, 515\u2013548. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115611 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"98135_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/imt-2017-0120","volume":"10","author":"N Kuol","year":"2018","unstructured":"Kuol, N., Stojanovska, L., Nurgali, K. & Apostolopoulos, V. Pd-1\/Pd-L1 in disease. Immunotherapy 10, 149\u2013160. https:\/\/doi.org\/10.2217\/imt-2017-0120 (2018).","journal-title":"Immunotherapy"},{"key":"98135_CR3","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3389\/fimmu.2019.02298","volume":"10","author":"W Qin","year":"2019","unstructured":"Qin, W. et al. The diverse function of Pd-1\/Pd-L pathway beyond cancer. Front. Immunol. 10, 2298. https:\/\/doi.org\/10.3389\/fimmu.2019.02298 (2019).","journal-title":"Front. Immunol."},{"key":"98135_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellimm.2016.09.009","volume":"310","author":"MR Zamani","year":"2016","unstructured":"Zamani, M. R., Aslani, S., Salmaninejad, A., Javan, M. R. & Rezaei, N. Pd-1\/Pd-L and autoimmunity: A growing relationship. Cell. Immunol. 310, 27\u201341. https:\/\/doi.org\/10.1016\/j.cellimm.2016.09.009 (2016).","journal-title":"Cell. Immunol."},{"key":"98135_CR5","doi-asserted-by":"publisher","unstructured":"Curnock, A. P. et al. Cell-targeted Pd-1 agonists that mimic Pd-L1 are potent T cell inhibitors. JCI Insight  6 https:\/\/doi.org\/10.1172\/jci.insight.152468 (2021).","DOI":"10.1172\/jci.insight.152468"},{"key":"98135_CR6","doi-asserted-by":"publisher","unstructured":"Bryan, C. M. et al. Computational design of a synthetic Pd-1 agonist. Proc. Natl. Acad. Sci. USA  118 https:\/\/doi.org\/10.1073\/pnas.2102164118 (2021).","DOI":"10.1073\/pnas.2102164118"},{"key":"98135_CR7","doi-asserted-by":"publisher","first-page":"15177","DOI":"10.1021\/bi970147b","volume":"36","author":"JF Hunt","year":"1997","unstructured":"Hunt, J. F., Rath, P., Rothschild, K. J., Engelman, D. M. & Spontaneous Ph-dependent membrane insertion of a transbilayer alpha-helix. Biochemistry 36, 15177\u201315192. https:\/\/doi.org\/10.1021\/bi970147b (1997).","journal-title":"Biochemistry"},{"key":"98135_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature13905","volume":"518","author":"CJ Cheng","year":"2015","unstructured":"Cheng, C. J. et al. Microrna Silencing for cancer therapy targeted to the tumour microenvironment. Nature 518, 107\u2013110. https:\/\/doi.org\/10.1038\/nature13905 (2015).","journal-title":"Nature"},{"key":"98135_CR9","doi-asserted-by":"publisher","first-page":"11607","DOI":"10.1038\/s41598-019-48104-5","volume":"9","author":"SM Son","year":"2019","unstructured":"Son, S. M. et al. Therapeutic effect of phlip-mediated Ceacam6 gene Silencing in lung adenocarcinoma. Sci. Rep. 9, 11607. https:\/\/doi.org\/10.1038\/s41598-019-48104-5 (2019).","journal-title":"Sci. Rep."},{"key":"98135_CR10","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1073\/pnas.0601463103","volume":"103","author":"YK Reshetnyak","year":"2006","unstructured":"Reshetnyak, Y. K., Andreev, O. A., Lehnert, U. & Engelman, D. M. Translocation of molecules into cells by Ph-dependent insertion of a transmembrane helix. Proc. Natl. Acad. Sci. USA  103, 6460\u20136465. https:\/\/doi.org\/10.1073\/pnas.0601463103 (2006).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"98135_CR11","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.1021\/acs.jmedchem.0c00016","volume":"63","author":"J Wehr","year":"2020","unstructured":"Wehr, J. et al. Ph-dependent grafting of cancer cells with antigenic epitopes promotes selective antibody-mediated cytotoxicity. J. Med. Chem. 63, 3713\u20133722. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00016 (2020).","journal-title":"J. Med. Chem."},{"key":"98135_CR12","doi-asserted-by":"publisher","first-page":"794226","DOI":"10.3389\/fimmu.2021.794226","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. Ph low insertion peptide-modified programmed cell death-ligand 1 potently suppresses T-cell activation under acidic condition. Front. Immunol. 12, 794226. https:\/\/doi.org\/10.3389\/fimmu.2021.794226 (2021).","journal-title":"Front. Immunol."},{"key":"98135_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbcan.2009.11.002","volume":"1805","author":"A Marusyk","year":"2010","unstructured":"Marusyk, A. & Polyak, K. Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta. 1805, 105\u2013117. https:\/\/doi.org\/10.1016\/j.bbcan.2009.11.002 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"98135_CR14","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1021\/bi400252k","volume":"52","author":"J Fendos","year":"2013","unstructured":"Fendos, J., Barrera, F. N. & Engelman, D. M. Aspartate embedding depth affects Phlip\u2019s insertion Pka. Biochemistry 52, 4595\u20134604. https:\/\/doi.org\/10.1021\/bi400252k (2013).","journal-title":"Biochemistry"},{"key":"98135_CR15","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1002\/anie.201409770","volume":"54","author":"JO Onyango","year":"2015","unstructured":"Onyango, J. O. et al. Noncanonical amino acids to improve the ph response of Phlip insertion at tumor acidity. Angew. Chem. Int. Ed. Engl. 54, 3658\u20133663. https:\/\/doi.org\/10.1002\/anie.201409770 (2015).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"98135_CR16","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1182\/blood-2007-07-100057","volume":"111","author":"JD Coudert","year":"2008","unstructured":"Coudert, J. D., Scarpellino, L., Gros, F., Vivier, E. & Held, W. Sustained Nkg2d engagement induces cross-tolerance of multiple distinct Nk cell activation pathways. Blood 111, 3571\u20133578. https:\/\/doi.org\/10.1182\/blood-2007-07-100057 (2008).","journal-title":"Blood"},{"key":"98135_CR17","doi-asserted-by":"publisher","unstructured":"Zak, K. M. et al. Structural biology of the immune checkpoint receptor Pd-1 and its ligands Pd-L1\/Pd-L2. Structure 25, 1163\u20131174  https:\/\/doi.org\/10.1016\/j.str.2017.06.011 (2017).","DOI":"10.1016\/j.str.2017.06.011"},{"key":"98135_CR18","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/anie.201006757","volume":"50","author":"X Lin","year":"2011","unstructured":"Lin, X. et al. Hybrid ferritin nanoparticles as activatable probes for tumor imaging. Angew Chem. Int. Ed. Engl. 50, 1569\u20131572. https:\/\/doi.org\/10.1002\/anie.201006757 (2011).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"98135_CR19","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1002\/smll.201300600","volume":"9","author":"T Ji","year":"2013","unstructured":"Ji, T. et al. Tumor fibroblast specific activation of a hybrid ferritin nanocage-based optical probe for tumor microenvironment imaging. Small 9, 2427\u20132431. https:\/\/doi.org\/10.1002\/smll.201300600 (2013).","journal-title":"Small"},{"key":"98135_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","volume":"21","author":"M Certo","year":"2021","unstructured":"Certo, M., Tsai, C. H., Pucino, V., Ho, P. C. & Mauro, C. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat. Rev. Immunol. 21, 151\u2013161. https:\/\/doi.org\/10.1038\/s41577-020-0406-2 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"98135_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-019-0259-8","volume":"20","author":"LB Ivashkiv","year":"2020","unstructured":"Ivashkiv, L. B. The hypoxia-lactate axis tempers inflammation. Nat. Rev. Immunol. 20, 85\u201386. https:\/\/doi.org\/10.1038\/s41577-019-0259-8 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"98135_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tibtech.2017.03.014","volume":"35","author":"LC Wyatt","year":"2017","unstructured":"Wyatt, L. C., Lewis, J. S., Andreev, O. A., Reshetnyak, Y. K. & Engelman, D. M. Applications of Phlip technology for cancer imaging and therapy. Trends Biotechnol. 35, 653\u2013664. https:\/\/doi.org\/10.1016\/j.tibtech.2017.03.014 (2017).","journal-title":"Trends Biotechnol."},{"key":"98135_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41385-019-0237-2","volume":"13","author":"IM Cartwright","year":"2020","unstructured":"Cartwright, I. M. et al. Adaptation to inflammatory acidity through neutrophil-derived adenosine regulation of Slc26a3. Mucosal Immunol. 13, 230\u2013244. https:\/\/doi.org\/10.1038\/s41385-019-0237-2 (2020).","journal-title":"Mucosal Immunol."},{"key":"98135_CR24","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1073\/pnas.0914330107","volume":"107","author":"OA Andreev","year":"2010","unstructured":"Andreev, O. A. et al. Ph (Low) insertion peptide (Phlip) inserts across a lipid bilayer as a helix and exits by a different path. Proc. Natl. Acad. Sci. USA 107, 4081\u20134086. https:\/\/doi.org\/10.1073\/pnas.0914330107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"98135_CR25","doi-asserted-by":"publisher","first-page":"e2214912120","DOI":"10.1073\/pnas.2214912120","volume":"120","author":"Z Zong","year":"2023","unstructured":"Zong, Z., Liu, X., Ye, Z. & Liu, D. A. Double-switch Phlip system enables selective enrichment of Circulating tumor microenvironment-derived extracellular vesicles. Proc. Natl. Acad. Sci. USA 120, e2214912120. https:\/\/doi.org\/10.1073\/pnas.2214912120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"98135_CR26","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1016\/j.jmb.2019.10.016","volume":"431","author":"V Vasquez-Montes","year":"2019","unstructured":"Vasquez-Montes, V., Gerhart, J., Th\u00e9venin, D. & Ladokhin, A. S. Divalent cations and lipid composition modulate membrane insertion and cancer-targeting action of Phlip. J. Mol. Biol. 431, 5004\u20135018. https:\/\/doi.org\/10.1016\/j.jmb.2019.10.016 (2019).","journal-title":"J. Mol. Biol."},{"key":"98135_CR27","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.bpj.2018.11.002","volume":"115","author":"C Gupta","year":"2018","unstructured":"Gupta, C., Ren, Y. & Mertz, B. Cooperative nonbonded forces control membrane binding of the Ph-low insertion peptide Phlip. Biophys. J. 115, 2403\u20132412. https:\/\/doi.org\/10.1016\/j.bpj.2018.11.002 (2018).","journal-title":"Biophys. J."},{"key":"98135_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.bpj.2015.01.002","volume":"108","author":"A Kyrychenko","year":"2015","unstructured":"Kyrychenko, A., Vasquez-Montes, V., Ulmschneider, M. B. & Ladokhin, A. S. Lipid headgroups modulate membrane insertion of Phlip peptide. Biophys. J. 108, 791\u2013794. https:\/\/doi.org\/10.1016\/j.bpj.2015.01.002 (2015).","journal-title":"Biophys. J."},{"key":"98135_CR29","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.bpj.2018.03.036","volume":"114","author":"AG Karabadzhak","year":"2018","unstructured":"Karabadzhak, A. G. et al. Bilayer thickness and curvature influence binding and insertion of a Phlip peptide. Biophys. J. 114, 2107\u20132115. https:\/\/doi.org\/10.1016\/j.bpj.2018.03.036 (2018).","journal-title":"Biophys. J."},{"key":"98135_CR30","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.bpj.2019.03.003","volume":"116","author":"HL Scott","year":"2019","unstructured":"Scott, H. L., Heberle, F. A., Katsaras, J. & Barrera, F. N. Phosphatidylserine asymmetry promotes the membrane insertion of a transmembrane helix. Biophys. J. 116, 1495\u20131506. https:\/\/doi.org\/10.1016\/j.bpj.2019.03.003 (2019).","journal-title":"Biophys. J."},{"key":"98135_CR31","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.bpj.2019.07.034","volume":"117","author":"J Westerfield","year":"2019","unstructured":"Westerfield, J. et al. Ions modulate key interactions between Phlip and lipid membranes. Biophys. J. 117, 920\u2013929. https:\/\/doi.org\/10.1016\/j.bpj.2019.07.034 (2019).","journal-title":"Biophys. J."},{"key":"98135_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41927-020-00171-2","volume":"5","author":"M Canavan","year":"2021","unstructured":"Canavan, M., Floudas, A., Veale, D. J. & Fearon, U. The Pd-1:Pd-L1 Axis in inflammatory arthritis. BMC Rheumatol. 5, 1. https:\/\/doi.org\/10.1186\/s41927-020-00171-2 (2021).","journal-title":"BMC Rheumatol."},{"key":"98135_CR33","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s13340-020-00466-2","volume":"11","author":"A Imagawa","year":"2020","unstructured":"Imagawa, A. & Tachibana, M. Fulminant type 1 diabetes: recent research progress and future prospects. Diabetol. Int. 11, 336\u2013341. https:\/\/doi.org\/10.1007\/s13340-020-00466-2 (2020).","journal-title":"Diabetol. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98135-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T09:45:07Z","timestamp":1744969507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98135-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98135"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98135-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. All animal experiments were approved by the Animal Ethics Committee of the Beijing Institute of Pharmacology and Toxicology (IACUC-DWZX-2020-697), and carried out in accordance with Regulations for the administration of affairs concerning experimental animals. The ARRIVE guidelines have been followed for conducting and reporting animal experiments. All experiments involving human subjects were approved by the Ethics Committee of Inner Mongolia Medical University (YKD202201152). All participants were provided with information regarding the study and gave their written informed consent prior to participation. This study was conducted in compliance with the Declaration of Helsinki and all applicable ethical guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"13422"}}